Next Article in Journal
Synthesis and Characterization of Nanocomposite Hydrogels Based on Poly(Sodium 4-Styrene Sulfonate) under Very-High Concentration Regimen of Clays (Bentonite and Kaolinite)
Previous Article in Journal
The Application Potential of Artificial Intelligence and Numerical Simulation in the Research and Formulation Design of Drilling Fluid Gel Performance
Previous Article in Special Issue
Sustained Release of Voriconazole Using 3D-Crosslinked Hydrogel Rings and Rods for Use in Corneal Drug Delivery
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Gels
Volume 10
Issue 6
10.3390/gels10060404
gels-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors

by
Jingru Yang
1,2,
Zhijie Wang
2,
Chenyan Ma
2,
Hongyu Tang
2,
Haoyang Hao
2,
Mengyao Li
2,
Xianwei Luo
2,
Mingxin Yang
2,
Liang Gao
1,* and
Juan Li
2,*
1
Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China
2
CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, China
*
Authors to whom correspondence should be addressed.
Gels 2024, 10(6), 404; https://doi.org/10.3390/gels10060404
Submission received: 21 May 2024 / Revised: 5 June 2024 / Accepted: 9 June 2024 / Published: 17 June 2024
(This article belongs to the Special Issue Advanced Hydrogels for Controlled Drug Delivery (2nd Edition))
Browse Figures
Review Reports Versions Notes

Abstract

:
The management of brain tumors presents numerous challenges, despite the employment of multimodal therapies including surgical intervention, radiotherapy, chemotherapy, and immunotherapy. Owing to the distinct location of brain tumors and the presence of the blood–brain barrier (BBB), these tumors exhibit considerable heterogeneity and invasiveness at the histological level. Recent advancements in hydrogel research for the local treatment of brain tumors have sought to overcome the primary challenge of delivering therapeutics past the BBB, thereby ensuring efficient accumulation within brain tumor tissues. This article elaborates on various hydrogel-based delivery vectors, examining their efficacy in the local treatment of brain tumors. Additionally, it reviews the fundamental principles involved in designing intelligent hydrogels that can circumvent the BBB and penetrate larger tumor areas, thereby facilitating precise, controlled drug release. Hydrogel-based drug delivery systems (DDSs) are posited to offer a groundbreaking approach to addressing the challenges and limitations inherent in traditional oncological therapies, which are significantly impeded by the unique structural and pathological characteristics of brain tumors.

1. Introduction

Malignant brain tumors, including prevalent types such as glioblastoma, are histologically diverse and aggressively invasive neoplasms, leading to high morbidity rates [1]. Glioblastoma is categorized as a grade IV glioma according to the World Health Organization (WHO) guidelines, with over two-thirds of primary brain tumors being aggressive in nature [2,3]. The prognosis for patients diagnosed with glioblastoma is dire, with median survival times of less than one year in half of the cases [4]. The treatment of brain tumors is particularly challenging due to their unique location and the constraints imposed by the blood–brain barrier (BBB) [5,6,7]. In recent years, there has been a growing interest in the application of hydrogels in the field of brain tumor treatment [8,9,10,11]. BCNU (carmustine) is a chemotherapy agent commonly utilized in the management of glioblastoma. However, its intravenous administration is associated with a short plasma half-life of merely 15–20 min and the potential for severe complications when plasma concentrations exceed 1400 mg [12]. To extend its therapeutic duration and mitigate adverse effects, researchers have explored alternative delivery modalities, notably employing localized therapy through the incorporation of BCNU into implantable biodegradable matrices [13]. Hydrogels, characterized by their biodegradability and excellent biocompatibility, offer a promising platform for targeted delivery directly to tumor sites, thereby significantly augmenting therapeutic efficacy [14,15,16].
Hydrogels serve as localized delivery reservoirs capable of loading drugs and precisely controlling drug release through external stimuli. For instance, Turabee and his colleagues developed a thermosensitive hydrogel incorporating nanoparticles loaded with docetaxel, thus creating a multimodal therapeutic approach [17]. This hydrogel not only delivers chemotherapeutic agents but also intelligently releases drugs to eradicate tumor cells. Additionally, hydrogels can be utilized for the delivery of immune modulators to enhance tumor immune responses. For example, Cui and colleagues designed a hydrogel containing anti-PD-1 antibodies for the local release of immune checkpoint inhibitors, thereby activating the patient’s immune system to target tumor cells [18]. This localized delivery system minimizes the systemic side effects while improving therapeutic efficacy [19,20]. Hydrogels are also employed as gene therapy carriers, facilitating the targeted delivery of gene editing tools or therapeutic genes directly to tumor cells. For instance, Chen and his colleagues utilized hydrogels to deliver the CRISPR/Cas9 system, targeting and cleaving specific oncogenes in glioblastoma [21]. This approach holds promise for directly inhibiting tumor growth through genetic modification [22,23].
Researchers continue to explore novel hydrogels with unique properties and investigate new applications. This paper provides an overview of the recent applications of hydrogels in drug delivery systems and the intelligent control of drug release, as illustrated in Figure 1 [24,25,26]. By summarizing the materials, characteristics, and application methods of hydrogels, they are categorized into injectable hydrogels, sprayable hydrogels, and implantable hydrogels [27,28,29,30]. Additionally, this article summarizes the specific applications of smart hydrogels in the treatment of brain tumors, including temperature- and pH-responsive hydrogels, photoresponsive hydrogels, and magnetic-responsive hydrogels [31,32,33,34]. Due to the rich water content and soft texture of brain tissue, hydrogels exhibit excellent biocompatibility and are more suitable for the unique environment of the brain [15]. The human body mainly consists of hydrogels and skeletal structures, which is also a crucial reason for the widespread application of hydrogels in the biomedical field. Therefore, drug delivery systems based on hydrogels hold promise for the provision of new therapeutic strategies to address the limitations of brain tumors with unique physiological and pathological structures. [35].
Gels 10 00404 g001
Figure 1. Hydrogels recently developed in drug delivery systems and intelligent drug release control for the treatment of brain tumors.
Figure 1. Hydrogels recently developed in drug delivery systems and intelligent drug release control for the treatment of brain tumors.
Gels 10 00404 g001

2. Hydrogels for the Local Treatment of Brain Tumors

Researchers have made significant progress in developing hydrogels capable of efficiently encapsulating anti-tumor drugs and releasing them in a controlled manner [36,37]. For brain tumors, hydrogels are specifically designed as precise DDSs that bypass the BBB, directly targeting the lesion and reducing systemic side effects [38,39,40,41]. The incorporation of nanoparticles within the hydrogel matrix enables targeted drug delivery. This method permits the direct injection of hydrogel into the tumor cavity or resection site, ensuring the effective delivery of therapeutic agents to tumor cells [3,42]. This section summarizes the different hydrogels used for the local treatment of cancer. The classification is based on the administration method, gelator material, and delivery characteristics (Table 1). It is evident from the table that the predominant treatment methods for brain tumors involve injections, with some emerging techniques using sprays and implantations [43,44].

2.1. Injectable Hydrogels

Injectable hydrogels are a specialized type of hydrogel material, typically in a liquid or semi-fluid state, which can be injected into the human tissue using a syringe or similar device, subsequently forming a gel-like state within the body. These hydrogels are commonly composed of polymer materials such as gelatin, hydroxyethyl methacrylate (HEMA), or polyethylene glycol (PEG). The notable research outlined in the literature demonstrates that Kang et al. developed an injectable, thermally responsive hydrogel nanocomposite for the treatment of glioblastoma multiforme Figure 2a [45]. Following surgical intervention, the injection of this hydrogel nanocomposite into the excised tumor site enables it to transition rapidly from a liquid to a gel state at body temperature [46]. This nanocomposite is not only responsive to thermal changes but also functions as a soft, deep intracortical reservoir for drug delivery, thereby facilitating the post-operative elimination of tumor cells [47,48].
Moreover, the surgical excision of a tumor allows for the collection of residual GBM cells by injecting biomaterials into the resection cavity [49,50]. Khan and his colleagues developed an injectable hydrogel based on polyethylene glycol and conducted studies on hydrogels with varied physical and chemical properties by manipulating parameters such as hydration level and the concentration of NaHCO3 in aqueous solution Figure 2b [51]. This formulation exhibits minimal and slow swelling over time, potentially reducing damage to healthy neurons post-implantation into the resection cavity. It maintains stability for up to two weeks and is both biocompatible with brain tissue and biodegradable.
In addition to acting as deep drug reservoirs, hydrogels can also stimulate anti-tumor immunity post-GBM resection, reducing recurrence [52,53]. Zhang and colleagues introduced an injectable hydrogel system containing a tumor-specific immune nanomodulator, which fosters sustained T-cell infiltration, as shown in Figure 2c [54]. When administered into the cavity of a surgically removed tumor, this hydrogel system replicates the immune ecological niche of a “hot tumor”, targeting any residual tumor cells and effectively diminishing the recurrence of GBM following surgery [55].
Gels 10 00404 g002
Figure 2. Schematic representation of injectable hydrogels for the treatment of brain tumors. (a) Intracortical injectable hydrogel composite nanomaterials were used to treat GBM. Adapted with permission from Kang et al. [45]. Copyright 2023 American Chemical Society. (b) To identify the optimal formulation for glioblastoma treatment, nine hydrogel formulations were characterized to determine the structure–property relationship between hydration/alkalinity and hydrogel properties. Adapted with permission from Khan et al. [51]. Copyright 2022 Elsevier. (c) A drug delivery system made of hydrogel that imitates a “hot tumor” immune niche locally. Adapted with permission from Zhang et al. [54]. Copyright 2021 Nature Research.
Figure 2. Schematic representation of injectable hydrogels for the treatment of brain tumors. (a) Intracortical injectable hydrogel composite nanomaterials were used to treat GBM. Adapted with permission from Kang et al. [45]. Copyright 2023 American Chemical Society. (b) To identify the optimal formulation for glioblastoma treatment, nine hydrogel formulations were characterized to determine the structure–property relationship between hydration/alkalinity and hydrogel properties. Adapted with permission from Khan et al. [51]. Copyright 2022 Elsevier. (c) A drug delivery system made of hydrogel that imitates a “hot tumor” immune niche locally. Adapted with permission from Zhang et al. [54]. Copyright 2021 Nature Research.
Gels 10 00404 g002

2.2. Sprayable Hydrogels

Sprayable hydrogels are hydrogels that can be applied to specific surfaces or tissues in the form of a spray. They typically consist of a gel solution or gel slurry with high water content, which can be ejected in liquid form through a sprayer or similar device and rapidly form a hydrogel network structure on the target surface or tissue [56]. Key characteristics of these hydrogels include the following: (1) Ease of application. Sprayable hydrogels can be directly sprayed onto the area requiring treatment or coating, making the application process more convenient and precise. (2) Rapid formation. Upon application to the target surface or tissue, sprayable hydrogels swiftly form a gel network structure, thereby adhering to the desired location and exerting their therapeutic effects [57]. (3) Wide applicability. Due to their ability to be sprayed onto surfaces or tissues of varying shapes and sizes, sprayable hydrogels find utility across diverse fields, including medicine, drug delivery, tissue engineering, and biomedical applications [58]. (4) Controlled release. Sprayable hydrogels can encapsulate drugs or bioactive substances, immobilizing them within the hydrogel network, and achieve the controlled release of these agents by controlling the composition and structure of the hydrogel, thereby enabling localized therapeutic effects [59]. The delivery of drugs via sprayable hydrogels represents a novel approach in the treatment of brain tumors. McCrorie and colleagues employed a spray device to effectively apply pectin and polymer nanocrystals (containing etoposide and olaparib) to sites of surgical resection Figure 3a [60]. This marks the first reported instance of transporting pectin to the brain and utilizing a spray device in neurosurgery for the local administration of drugs around the incision site. As an innovative DDS, sprayable hydrogel not only mitigates the adverse effects of surgery but also has the potential to extend patient survival [61].

2.3. Implantable Hydrogels

Implantable hydrogels are a type of hydrogel material that can be implanted into the human body, typically designed for releasing drugs at specific locations, supporting tissue engineering, or promoting wound healing [62]. The applications of implantable hydrogels include the following: (1) localized hyperthermia. Some implantable hydrogels contain thermosensitive components, such as magnetic nanoparticles or thermosensitive drugs. When these hydrogels are implanted into brain tissue or around tumors, external magnetic fields or other heat sources can induce the release of thermosensitive components, achieving localized hyperthermia and helping to kill tumor cells [63]. (2) Assistance in radiotherapy. Implantable hydrogels can be used as adjuncts in radiotherapy. By embedding radioactive isotopes or radiotherapeutic drugs into hydrogels and implanting them around tumors, the precision and local chemotherapy effects of radiotherapy can be enhanced. (3) Surgical assistance. Implantable hydrogels can serve as surgical adjunct materials, such as intraoperative fillers or postoperative supports. They can be implanted at surgical sites to provide support and filling, reduce surgical trauma, and promote postoperative healing [64,65]. Implantable hydrogels could enable the adjustment of drug dosage based on the tumor’s characteristics, thus optimizing treatment and minimizing side effects [20]. This approach to personalized medicine holds the potential to transform the therapy of brain tumors. Wang and his colleagues developed a novel 3D-printed hydrogel nanoplatform for intracranial implantation Figure 3b [66]. Hydrogels act as drug reservoirs, and through the modification of targeted peptides, an effective DDS can be established. They also incorporated temozolomide and erastin into gelatin methacrylamide (GelMA) to induce synergistic effects in tumor treatment. The intracranial implantation of this hydrogel liposome system can enhance the sensitivity of chemotherapy drugs and also modulate the tumor microenvironment, showing considerable promise for the treatment of brain tumors [67].
Gels 10 00404 g003
Figure 3. Schematic representation of hydrogels for different modes of brain tumor delivery. (a) Schematic illustration of a local DDS consisting of a nebulizing device, pectin, and NCPPs. Adapted with permission from McCrorie et al. [60]. Copyright 2020 Elsevier. (b) Schematic illustration of a GelMA–liposome system that is coated with temozolomide and erastin. Adapted with permission from Wang et al. [66]. Copyright 2023 Elsevier.
Figure 3. Schematic representation of hydrogels for different modes of brain tumor delivery. (a) Schematic illustration of a local DDS consisting of a nebulizing device, pectin, and NCPPs. Adapted with permission from McCrorie et al. [60]. Copyright 2020 Elsevier. (b) Schematic illustration of a GelMA–liposome system that is coated with temozolomide and erastin. Adapted with permission from Wang et al. [66]. Copyright 2023 Elsevier.
Gels 10 00404 g003
Table 1. Methods of hydrogels for the delivery of brain tumors.
Table 1. Methods of hydrogels for the delivery of brain tumors.
Drug
Delivery Way		Hydrogel MaterialFeatureApplicationRef.
InjectionComposite nanohydrogels containing drug-loaded micelles and wFIONsInjectable heat-responsive systemOperative brain tumor therapy using injectable hydrogel nanocomposites[45]
Poly (ethylene glycol)-based hydrogel crosslinked by thiol-Michael addition reactionChemical and physical modalities were synergistically employed for therapeutic interventionInjectable sulfhydryl Michael addition hydrogel for glioblastoma therapy[51]
The gelato consists of 9-fluorenylmethoxycarbonyl Phe and Phe-Phe-dihydroxyphenylalanineBenign biodegradability and drug release propertiesTumor-killing immunity is stimulated after surgical resection of GBM to reduce its recurrence[54]
SprayPectin with nanocrystals coated with polylactic acid and polyethylene glycol (NCPPs)-loaded etoposide and olaparibDrugs are delivered using a spray deviceBioadhesive spray hydrogels containing etoposide and olaparib polymer-coated nanoparticles[60]
ImplantationTemozolomide + Erastin@liposome-cyclic RGD + gelatin methacrylamideThe orthotopic implantation procedure elicits ferroptosis and impedes tumor recurrenceThe platform of implantable hydrogels inhibits the recurrence of GBM by inducing ferroptosis[66]

3. Smart Hydrogels for Local Treatment of Brain Tumors

Smart hydrogels release encapsulated bioactive substances in response to external stimuli [68,69,70,71]. Hydrogels that are responsive to temperature, pH, light, and magnetism fall into the category of smart hydrogels. These external stimuli induce changes in the properties of the hydrogels [72,73]. In the context of treating brain tumors, smart hydrogels efficiently control drug release through external stimuli, significantly reducing systemic adverse reactions due to their excellent biocompatibility [74,75,76,77].

3.1. Temperature and pH—Responsive Hydrogels

Temperature-responsive hydrogels demonstrate varying behaviors in response to temperature fluctuations [78,79]. Temperature-responsive polymers undergo phase transitions above ambient temperatures and dissolve at lower temperatures (lower critical solution temperature (LCST)) [80]. When the temperature rises to LCST, the polymer changes from sol to gel. However, when the temperature-responsive polymer undergoes a phase transition below ambient temperature, it dissolves at higher temperatures (upper critical solution temperature (UCST)) [81]. When the temperature is lower than UCST, the polymer turns into a gel state. In the present study, the temperature-responsive hydrogels with LCST have a good medical application prospect, mainly because the temperature-responsive hydrogels can form a gel state when they are close to human temperature. pH-responsive hydrogels are a type of smart hydrogel sensitive to changes in environmental pH. The ionizable groups within the network of pH-responsive hydrogels, such as carboxyl and amino groups, alter their dissociation states in response to environmental pH changes, thereby affecting the swelling behavior and properties of the hydrogel [82]. pH-responsive hydrogels are typically composed of polymers with acidic or basic functional groups. Common polymers include poly(acrylic acid), poly(methacrylic acid), and poly(2-vinylpyridine). pH-responsive hydrogels can be engineered to specifically deliver chemotherapeutic agents to tumor sites. Compared to normal tissues (approximately pH 7.4), the tumor microenvironment is often slightly acidic (approximately pH 6.5–6.8) [83]. Hydrogels can be designed to swell and release their drug payload in response to this acidic environment, ensuring that therapeutic agents are precisely released where needed, thus minimizing damage to healthy brain tissue [84,85,86].
Hydrogels that respond to both temperature and pH have the potential to facilitate the precise, targeted therapy of tumors under multiple stimuli, thereby proving highly effective in sustained-release applications [18]. Kang and colleagues developed a gelatin hydrogel with dual stimulus responsiveness, grafted with oligomeric sulfadiazine (OSM) and combined with paclitaxel (PTX) to inhibit GBM progression Figure 4a [87]. This gelatin-OSM complex transitions from a fluid to a gel state dependent on temperature and pH, maintaining its gel state for approximately ten days. The dual-responsive hydrogel thus provides sustained drug release within the tumor environment, effectively impeding GBM progression.

3.2. Photoresponsive Hydrogels

In the near infrared–ultraviolet/visible (NIR-UV/VIS) spectrum, water is nearly transparent [88,89]. Photoresponsive hydrogels alter their morphology in response to photo irradiation through the absorption or release of water [90,91,92]. Consequently, hydrogels are well-suited as photoresponsive biomaterials. The chemical and physical versatility of hydrogels, combined with their photoresponsiveness, makes them ideal for a range of applications, spanning from biomaterials to biomedicine [93]. Zhao and colleagues explored a local DDS based on photopolymerizable hydrogels for postoperative GBM treatment Figure 4b [94]. Upon photo irradiation, the hydrogel not only forms rapidly but also exhibits low swelling, thereby preventing an increase in intracranial pressure [95,96]. To enhance the therapeutic efficacy against GBM, they incorporated paclitaxel (PTX) and temozolomide (TMZ) into the hydrogels to create a combined DDS [97,98]. In a U87MG orthotopic transplantation tumor model, the hydrogel proved suitable for implantation post-tumor resection, demonstrating the excellent sustained-release capabilities of the drug [99,100,101]. There has been a marked increase in the development of photoresponsive hydrogels in recent years [102]. These hydrogels possess physical and chemical characteristics akin to the flexible materials found in living systems [103]. One of the primary advantages of photoresponsive hydrogels is their cost-effectiveness, coupled with their ability to achieve non-contact and spatiotemporal control. These properties render them excellent candidates for applications in biomaterials and biomedicine [104].

3.3. Magnetic-Responsive Hydrogels

Magnetic-responsive hydrogels are typically fabricated by incorporating micron or nanometer-sized magnetic particles, such as Fe2O3 and Fe3O4 [105,106]. When subjected to an external magnetic field, the hydrogel’s magnetic nanoparticles can be released with precision [107]. Magnetic fields offer advantages over other stimuli as they are contactless and relatively straightforward to manipulate, making them particularly suitable for biomedical applications [108]. Kang and colleagues have recently reported the use of magnetically responsive hydrogels in the treatment of brain tumors Figure 4c [45]. Following surgical intervention, the hydrogel, injected into the site of the excised brain tumor, rapidly transitions to a gel state at body temperature. Under alternating magnetic fields, the hydrogel, mixed with water-dispersible ferrimagnetic iron oxide nanocubes (wFIONs), generates heat, accelerating the micelle process. Consequently, the release and diffusion of the drug can penetrate a centimeter deep, facilitating precise drug delivery for brain tumor treatment. Magnetic-responsive hydrogels hold significant potential for targeted tumor therapy, with diverse applications including magnetically controlled drug release, magnetic hyperthermia, and magnetic targeting [109].
Gels 10 00404 g004
Figure 4. Schematic representation of smart hydrogels for the treatment of brain tumors. (a) In situ injection of gelatin–OSM hydrogel to inhibit tumor recurrence. Adapted with permission from Kang et al. [87]. Copyright 2021 Elsevier. (b) Codelivery of PTX and TMZ through a photoresponsive hydrogel for the postresection therapy of GBM. Adapted with permission from Zhao et al. [94]. Copyright 2019 Elsevier. (c) The magnetic-responsive hydrogel precisely delivers wFIONs deep into the brain tumor. Adapted with permission from Kang et al. [45]. Copyright 2023 American Chemical Society.
Figure 4. Schematic representation of smart hydrogels for the treatment of brain tumors. (a) In situ injection of gelatin–OSM hydrogel to inhibit tumor recurrence. Adapted with permission from Kang et al. [87]. Copyright 2021 Elsevier. (b) Codelivery of PTX and TMZ through a photoresponsive hydrogel for the postresection therapy of GBM. Adapted with permission from Zhao et al. [94]. Copyright 2019 Elsevier. (c) The magnetic-responsive hydrogel precisely delivers wFIONs deep into the brain tumor. Adapted with permission from Kang et al. [45]. Copyright 2023 American Chemical Society.
Gels 10 00404 g004

4. Advantages of Hydrogels in the Treatment of Brain Tumors

Despite significant advances in biomedicine, malignant brain tumors remain a formidable challenge, with a cure remaining elusive. The BBB significantly impedes therapeutic efficacy, primarily by restricting the entry of large molecules and over 90% of small molecular drugs into the brain [110,111,112,113]. Additionally, the invasive nature of brain tumors further complicates treatment, with tumor cells infiltrating surrounding healthy brain parenchyma and developing mechanisms of multidrug resistance. These factors collectively pose substantial challenges in brain tumor therapy [114].
Hydrogels exhibit remarkable properties stemming from their crosslinked polymer networks, which enable them to retain substantial amounts of water within their structure [115,116]. As depicted in Figure 5, hydrogels can be classified into physical, chemical, and dual network hydrogels based on their crosslinking mechanisms [117]. Table 2 summarizes the advantages and disadvantages of the different types of hydrogels. The crosslinking in physical hydrogels primarily occurs through physical interactions such as hydrophobic association, chain aggregation, crystallization, polymer chain complexation, and hydrogen bonding [118]. The shortcomings of physical hydrogels manifest in several ways: (1) Low mechanical strength. Due to their weaker crosslinking interactions, these hydrogels have reduced mechanical strength and stability. (2) Lower stability. Physical crosslinking points, formed by weaker interactions like hydrogen bonds, may lead to long-term stability issues such as point fracture. (3) Limited control. Achieving precise control over crosslinking density and structure is challenging, hindering the finetuning of the hydrogel’s properties [119]. Despite these shortcomings, physical hydrogels offer the following notable advantages: (1) Mild conditions and a simple preparation: These hydrogels can form at room temperature, with synthesis easily adjusted by alterations in the solution temperature or pH, aiding cost-effective large-scale production. (2) Reversibility. Their reversible nature allows for swelling or shrinking in response to external changes, facilitating reuse. (3) Tunability. Various properties can be achieved by selecting different physical crosslinking mechanisms and adjusting conditions [120].
Gels 10 00404 g005
Figure 5. Hydrogels are prepared by physical crosslinking, chemical crosslinking, and dual networks.
Figure 5. Hydrogels are prepared by physical crosslinking, chemical crosslinking, and dual networks.
Gels 10 00404 g005
Chemical hydrogels, on the other hand, are synthesized through covalent crosslinking or post-polymerization. Chemical hydrogels may present the following drawbacks: (1) Potential toxicity. Chemical crosslinking agents, such as formaldehyde and glutaraldehyde, can be toxic. In biomedical applications, it is imperative to ensure that residual levels of chemical crosslinking agents are minimized to non-toxic levels [121]. (2) Complex preparation. Chemical crosslinking processes typically require precise control over the reaction temperature and time, and may involve multiple steps of chemical processing. (3) Poor reversibility. Chemical hydrogels form crosslinking points through covalent bonds, making it challenging to reverse their structure and morphology again. In addition, the advantages of chemical hydrogels are as follows: (1) High mechanical strength. Chemical hydrogels exhibit an elevated mechanical strength and elastic modulus due to their stable covalent bond formation [122]. (2) Stability. They maintain their structural integrity and performance across diverse environmental conditions, making them suitable for long-term applications like tissue engineering scaffolds and sustained drug release systems. (3) Tunability. With varied crosslinking agents and conditions, the crosslinking density and pore structure of chemical hydrogels can be precisely controlled, enabling their properties to be tailored for specific applications [123,124,125]. Dual-network hydrogels integrate the strengths of both physical hydrogels and chemical hydrogels via the following characteristics: (1) High strength and toughness. They leverage a rigid, brittle first network for strength and a soft, stretchable second network for toughness, resulting in superior performance [126]. (2) High elasticity. These hydrogels maintain elasticity even under significant deformation, making them ideal for soft tissue engineering and biomimetic materials [127]. (3) Versatility. By adjusting the composition and crosslinking methods of both networks, multifunctional properties such as self-healing, conductivity, and responsiveness can be achieved. [128,129,130]. Certainly, dual-network hydrogels also exhibit certain disadvantages. For instance, there are limitations in material selection. Achieving synergy between the two networks necessitates stringent requirements for material compatibility and crosslinking conditions. By summarizing the unique advantages and drawbacks of each type of hydrogel, researchers can select suitable hydrogel materials according to their specific needs. This enables the more effective utilization of hydrogels in biomedical applications [131].
As exemplary biocompatible materials, hydrogels not only emulate the extracellular matrix in the brain but also establish ideal DDSs for the local treatment of brain tumors [132,133]. Hydrogels offer the following advantages as DDSs: (1) Biocompatibility. Hydrogels closely resemble human tissues in their properties. When drugs are encapsulated within hydrogels, they not only avert the rapid degradation of chemotherapy drugs in the body but also shield the brain from drug-related toxicity [134,135]. (2) Biodegradability. Ideally, the interaction between the host tissue and the hydrogel should orchestrate and finetune the degradation process, leading to its eventual disappearance [136]. (3) Intelligent drug release control. Smart hydrogels are particularly effective for targeting tumors due to their capacity to respond to various external stimuli and precisely regulate drug release [137,138,139]. (4) Accessibility. Hydrogels can be easily synthesized and mass-produced through chemical methods with a low ecological impact [140,141,142]. Currently, researchers in the field of hydrogels are developing multiple types and modes of hydrogel drug delivery systems, aiming to significantly contribute to the clinical treatment of brain tumors [143,144,145,146].
Table 2. Properties of hydrogels with different mechanisms.
Table 2. Properties of hydrogels with different mechanisms.
Various Types of HydrogelsCrosslinking MechanismsAdvantagesDisadvantages
Physical hydrogels
  • Hydrophobic association
  • Chain aggregation
  • Crystallization
  • Polymer chain complexation
  • Hydrogen bonding
  • Mild conditions
  • Reversibility
  • Tunability
  • Low mechanical strength
  • Lower stability
  • Limited control
Chemical hydrogels
  • Covalent crosslinking
  • Post-polymerization.
  • High mechanical strength
  • Stability
  • Tunability
  • Potential toxicity
  • Complex preparation
  • Poor reversibility
Dual-network hydrogels
  • Physical and chemical interaction
  • High strength and toughness
  • High elasticity
  • Versatility
  • Limitations in material selection
  • Elaborate synthesis steps

5. Conclusions and Prospectives

Due to the complexity of the brain anatomy and the high sensitivity of the nervous system, achieving effective treatment for tumors remains challenging. Some contributing factors include the following: (1) Risk of local tissue damage. There is a potential risk of local tissue damage during the injection of hydrogels, especially during the use of injection needles and surgical procedures. (2) Uneven drug distribution. Due to the nature of local treatment, drug concentrations within tumor tissues may be uneven, leading to suboptimal treatment effects in certain areas. (3) Long-term safety concerns. The long-term safety of local hydrogel therapy for brain tumors remains incompletely understood, particularly regarding the prolonged release of drugs and their impact on the brain tissue and the surrounding environment, necessitating long-term observation and research.
This paper summarizes four key aspects: (1) Challenges in the treatment of brain tumors. (2) The use of drug delivery systems using different hydrogels, including injectable hydrogels, spray hydrogels, and implantable hydrogels, detailing their material composition, characteristics, and specific applications. (3) The widespread application of various types of smart hydrogels, such as temperature- and pH-responsive, photoresponsive, and magnetic-responsive hydrogels, in the treatment of brain tumors. (4) The advantages and disadvantages of hydrogels formed by different crosslinking methods. Through this summary, it is evident that while hydrogels face challenges in the clinical treatment of brain tumors, their unique properties hold promise for postoperative treatment following GBM resection. Additionally, smart hydrogels have significant potential in enhancing treatment efficacy and reducing side effects. The development of more sophisticated hydrogels and their optimization for various medical applications represents an actively explored field, indicating a promising future for personalized medicine.

Author Contributions

All authors contributed to writing, reviewing, and editing this work. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Key R&D Program of China grant number (No. 2022YFA1207300), the Science and Technology Plan Program of Beijing (Z221100007122006), and the National Natural Science Foundation of China (22122401).

Data Availability Statement

The original data presented in the study are openly available in Figure 2a at Ref. [45], Figure 2b at Ref. [51], Figure 2c at Ref. [54], Figure 3a at Ref. [60], Figure 3b at Ref. [66], Figure 4a at Ref. [87], Figure 4b at Ref. [94] and Figure 4c at Ref. [45].

Acknowledgments

This project was supported by the National Key R&D Program of China (No. 2022YFA1207300), the Science and Technology Plan Program of Beijing (Z221100007122006), and the National Natural Science Foundation of China (22122401).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Anderson, A.R.; Segura, T. Injectable Biomaterials for Treatment of Glioblastoma. Adv. Mater. Interfaces 2020, 7, 107–130. [Google Scholar] [CrossRef] [PubMed]
  2. Sun, Z.; Song, C.; Wang, C.; Hu, Y.; Wu, J. Hydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review. Mol. Pharm. 2020, 17, 373–391. [Google Scholar] [CrossRef] [PubMed]
  3. Zhao, Z.; Wang, Z.; Li, G.; Cai, Z.; Wu, J.; Wang, L.; Deng, L.; Cai, M.; Cui, W. Injectable Microfluidic Hydrogel Microspheres for Cell and Drug Delivery. Adv. Funct. Mater. 2021, 31, 2103339. [Google Scholar] [CrossRef]
  4. Yan, L.; Zhao, C.; Wang, Y.; Qin, Q.; Liu, Z.; Hu, Y.; Xu, Z.; Wang, K.; Jiang, X.; Han, L.; et al. Adhesive and conductive hydrogel-based therapy simultaneously targeting neuroinflammation and neurofunctional damage after brain injury. Nano Today 2023, 51, 150–167. [Google Scholar] [CrossRef]
  5. Kornev, V.A.; Grebenik, E.A.; Solovieva, A.B.; Dmitriev, R.I.; Timashev, P.S. Hydrogel-assisted neuroregeneration approaches towards brain injury therapy: A state-of-the-art review. Comput. Struct. Biotechnol. J. 2018, 16, 488–502. [Google Scholar] [CrossRef] [PubMed]
  6. Bharadwaj, V.N.; Nguyen, D.T.; Kodibagkar, V.D.; Stabenfeldt, S.E. Nanoparticle-Based Therapeutics for Brain Injury. Adv. Healthc. Mater. 2017, 7, 68–82. [Google Scholar] [CrossRef] [PubMed]
  7. Brown, T.D.; Habibi, N.; Wu, D.; Lahann, J.; Mitragotri, S. Effect of Nanoparticle Composition, Size, Shape, and Stiffness on Penetration Across the Blood-Brain Barrier. ACS Biomater. Sci. Eng. 2020, 6, 4916–4928. [Google Scholar] [CrossRef] [PubMed]
  8. Li, Q.; Shao, X.; Dai, X.; Guo, Q.; Yuan, B.; Liu, Y.; Jiang, W. Recent trends in the development of hydrogel therapeutics for the treatment of central nervous system disorders. NPG Asia Mater. 2022, 14, 27–41. [Google Scholar] [CrossRef]
  9. Norouzi, M.; Nazari, B.; Miller, D.W. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov. Today 2016, 21, 1835–1849. [Google Scholar] [CrossRef]
  10. Bastiancich, C.; Danhier, P.; Preat, V.; Danhier, F. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma. J. Control. Release 2016, 243, 29–42. [Google Scholar] [CrossRef]
  11. Basso, J.; Miranda, A.; Nunes, S.; Cova, T.; Sousa, J.; Vitorino, C.; Pais, A. Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors. Gels 2018, 4, 62. [Google Scholar] [CrossRef]
  12. Tabet, A.; Jensen, M.P.; Parkins, C.C.; Patil, P.G.; Watts, C.; Scherman, O.A. Designing Next-Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the Clinic. Adv. Healthc. Mater. 2019, 8, e1801391. [Google Scholar] [CrossRef] [PubMed]
  13. Chen, S.; Qiu, Q.; Wang, D.; She, D.; Yin, B.; Chai, M.; He, H.; Heo, D.N.; Wang, J. Long acting carmustine loaded natural extracellular matrix hydrogel for inhibition of glioblastoma recurrence after tumor resection. Front. Chem. Sci. Eng. 2021, 16, 536–545. [Google Scholar] [CrossRef]
  14. Rossi, S.M.; Murray, T.; McDonough, L.; Kelly, H. Loco-regional drug delivery in oncology: Current clinical applications and future translational opportunities. Expert Opin. Drug Deliv. 2021, 18, 607–623. [Google Scholar] [CrossRef]
  15. Ren, E.; Wang, Y.; Liang, T.; Zheng, H.; Shi, J.; Cheng, Z.; Li, H.; Gu, Z. Local Drug Delivery Techniques for Triggering Immunogenic Cell Death. Small Methods 2023, 7, e2300347. [Google Scholar] [CrossRef] [PubMed]
  16. Stawicki, B.; Schacher, T.; Cho, H. Nanogels as a Versatile Drug Delivery System for Brain Cancer. Gels 2021, 7, 63. [Google Scholar] [CrossRef]
  17. Turabee, M.H.; Jeong, T.H.; Ramalingam, P.; Kang, J.H.; Ko, Y.T. N,N,N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor. Carbohydr. Polym. 2019, 203, 302–309. [Google Scholar] [CrossRef] [PubMed]
  18. Cui, H.; Zhao, Y.Y.; Han, Y.H.; Lan, Z.; Zou, K.L.; Cheng, G.W.; Chen, H.; Zhong, P.L.; Chen, Y.; Ma, L.M.; et al. Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1. Acta Biomater. 2024, 180, 423–435. [Google Scholar] [CrossRef]
  19. Meng, J.; Yang, X.; Huang, J.; Tuo, Z.; Hu, Y.; Liao, Z.; Tian, Y.; Deng, S.; Deng, Y.; Zhou, Z.; et al. Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma. Adv. Sci. 2023, 10, e2300517. [Google Scholar] [CrossRef]
  20. Li, Y.; Fang, M.; Zhang, J.; Wang, J.; Song, Y.; Shi, J.; Li, W.; Wu, G.; Ren, J.; Wang, Z.; et al. Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Oncoimmunology 2016, 5, e1074374. [Google Scholar] [CrossRef]
  21. Chen, Z.; Liu, F.; Chen, Y.; Liu, J.; Wang, X.; Chen, A.T.; Deng, G.; Zhang, H.; Liu, J.; Hong, Z.; et al. Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles. Adv. Funct. Mater. 2017, 27, 1703036. [Google Scholar] [CrossRef] [PubMed]
  22. Iqbal, Z.; Rehman, K.; Xia, J.; Shabbir, M.; Zaman, M.; Liang, Y.; Duan, L. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing. Biomater. Sci. 2023, 11, 3762–3783. [Google Scholar] [CrossRef] [PubMed]
  23. Simonneau, C.; Duschmale, M.; Gavrilov, A.; Brandenberg, N.; Hoehnel, S.; Ceroni, C.; Lassalle, E.; Kassianidou, E.; Knoetgen, H.; Niewoehner, J.; et al. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays. Fluids Barriers CNS 2021, 18, 43. [Google Scholar] [CrossRef] [PubMed]
  24. Daly, A.C.; Riley, L.; Segura, T.; Burdick, J.A. Hydrogel microparticles for biomedical applications. Nat. Rev. Mater. 2020, 5, 20–43. [Google Scholar] [CrossRef]
  25. Zhu, Y.J.; Yang, Z.J.; Pan, Z.J.; Hao, Y.; Wang, C.J.; Dong, Z.L. Metallo-alginate hydrogel can potentiate microwave tumor ablation for synergistic cancer treatment. Sci. Adv. 2022, 8, 5285–5299. [Google Scholar] [CrossRef] [PubMed]
  26. Chen, D.; Ma, X.; Zhu, J.; Wang, Y.; Guo, S.; Qin, J. Pectin based hydrogel with covalent coupled doxorubicin and limonin loading for lung tumor therapy. Colloids Surf. B Biointerfaces 2024, 234, 113670. [Google Scholar] [CrossRef]
  27. Ayoubi-Joshaghani, M.H.; Seidi, K.; Azizi, M.; Jaymand, M.; Javaheri, T.; Jahanban-Esfahlan, R.; Hamblin, M.R. Potential Applications of Advanced Nano/Hydrogels in Biomedicine: Static, Dynamic, Multi-Stage, and Bioinspired. Adv. Funct. Mater. 2020, 30, 198–220. [Google Scholar] [CrossRef]
  28. Liu, X.; Liu, J.; Lin, S.; Zhao, X. Hydrogel machines. Mater. Today 2020, 36, 102–124. [Google Scholar] [CrossRef]
  29. Mondal, S.; Das, S.; Nandi, A.K. A review on recent advances in polymer and peptide hydrogels. Soft Matter 2020, 16, 1404–1454. [Google Scholar] [CrossRef]
  30. Sun, X.; Yang, X.; Chen, Y.; Sun, J.; He, Z.; Zhang, S.; Luo, C. In situ self-assembled nanomedicines for cancer treatment. Chem. Eng. J. 2023, 466, 1503–1529. [Google Scholar] [CrossRef]
  31. Che, L.; Lei, Z.; Wu, P.; Song, D. A 3D Printable and Bioactive Hydrogel Scaffold to Treat Traumatic Brain Injury. Adv. Funct. Mater. 2019, 29, 228–243. [Google Scholar] [CrossRef]
  32. Lee, J.; Cho, H.R.; Cha, G.D.; Seo, H.; Lee, S.; Park, C.K.; Kim, J.W.; Qiao, S.; Wang, L.; Kang, D.; et al. Flexible, sticky, and biodegradable wireless device for drug delivery to brain tumors. Nat. Commun. 2019, 10, 5205–5227. [Google Scholar] [CrossRef]
  33. Gou, S.; Meng, W.; Panayi, A.C.; Wang, R.; Zhang, R.; Gao, P.; He, T.; Geng, W.; Hu, S.; Yu, Y.; et al. Bioresponsive Self-Reinforcing Sericin/Silk Fibroin Hydrogel for Relieving the Immune-Related Adverse Events in Tumor Immunotherapy. Adv. Funct. Mater. 2023, 33, 188–216. [Google Scholar] [CrossRef]
  34. Liang, Q.; Shen, Z.; Sun, X.; Yu, D.; Liu, K.; Mugo, S.M.; Chen, W.; Wang, D.; Zhang, Q. Electron Conductive and Transparent Hydrogels for Recording Brain Neural Signals and Neuromodulation. Adv. Mater. 2023, 35, e2211159. [Google Scholar] [CrossRef] [PubMed]
  35. Wang, H.; Zhang, L.-M. Intelligent biobased hydrogels for diabetic wound healing: A review. Chem. Eng. J. 2024, 484, 1417–1432. [Google Scholar] [CrossRef]
  36. Bastiancich, C.; Vanvarenberg, K.; Ucakar, B.; Pitorre, M.; Bastiat, G.; Lagarce, F.; Preat, V.; Danhier, F. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. J. Control. Release 2016, 225, 283–293. [Google Scholar] [CrossRef] [PubMed]
  37. Tao, J.; Zhang, J.; Hu, Y.; Yang, Y.; Gou, Z.; Du, T.; Mao, J.; Gou, M. A conformal hydrogel nanocomposite for local delivery of paclitaxel. J. Biomater. Sci. Polym. Ed. 2017, 28, 107–118. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, F.; Su, H.; Lin, R.; Chakroun, R.W.; Monroe, M.K.; Wang, Z.; Porter, M.; Cui, H. Supramolecular Tubustecan Hydrogel as Chemotherapeutic Carrier to Improve Tumor Penetration and Local Treatment Efficacy. ACS Nano 2020, 14, 10083–10094. [Google Scholar] [CrossRef] [PubMed]
  39. Wang, K.; Wang, J.; Li, L.; Xu, L.; Feng, N.; Wang, Y.; Fei, X.; Tian, J.; Li, Y. Novel Nonreleasing Antibacterial Hydrogel Dressing by a One-Pot Method. ACS Biomater. Sci. Eng. 2020, 6, 1259–1268. [Google Scholar] [CrossRef]
  40. Gartner, Z.J.; Hu, J.L. Guiding tissue-scale self-organization. Nat. Mater. 2021, 20, 2–13. [Google Scholar] [CrossRef]
  41. Guan, Q.F.; Han, Z.M.; Zhu, Y.; Xu, W.L.; Yang, H.B.; Ling, Z.C.; Yan, B.B.; Yang, K.P.; Yin, C.H.; Wu, H.; et al. Bio-Inspired Lotus-Fiber-like Spiral Hydrogel Bacterial Cellulose Fibers. Nano Lett. 2021, 21, 952–958. [Google Scholar] [CrossRef]
  42. Cha, G.D.; Lee, W.H.; Sunwoo, S.H.; Kang, D.; Kang, T.; Cho, K.W.; Kim, M.; Park, O.K.; Jung, D.; Lee, J.; et al. Multifunctional Injectable Hydrogel for In Vivo Diagnostic and Therapeutic Applications. ACS Nano 2022, 16, 554–567. [Google Scholar] [CrossRef] [PubMed]
  43. Lee, C. Injectable glucose oxidase-immobilized gelatin hydrogel prevents tumor recurrence via oxidation therapy. Colloids Surf. B Biointerfaces 2023, 232, 113581. [Google Scholar] [CrossRef]
  44. Cheng, Z.; Xue, C.; Liu, M.; Cheng, Z.; Tian, G.; Li, M.; Xue, R.; Yao, X.; Zhang, Y.; Luo, Z. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment. Acta Biomater. 2023, 169, 289–305. [Google Scholar] [CrossRef] [PubMed]
  45. Kang, T.; Cha, G.D.; Park, O.K.; Cho, H.R.; Kim, M.; Lee, J.; Kim, D.; Lee, B.; Chu, J.; Koo, S.; et al. Penetrative and Sustained Drug Delivery Using Injectable Hydrogel Nanocomposites for Postsurgical Brain Tumor Treatment. ACS Nano 2023, 17, 5435–5447. [Google Scholar] [CrossRef]
  46. Li, J.; Luo, G.; Zhang, C.; Long, S.; Guo, L.; Yang, G.; Wang, F.; Zhang, L.; Shi, L.; Fu, Y.; et al. In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy. Mater. Today Bio 2022, 14, 100238. [Google Scholar] [CrossRef] [PubMed]
  47. Puente, P.; Fettig, N.; Luderer, M.J.; Jin, A.; Shah, S.; Muz, B.; Kapoor, V.; Goddu, S.M.; Salama, N.N.; Tsien, C.; et al. Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors. J. Pharm. Sci. 2018, 107, 922–933. [Google Scholar] [CrossRef] [PubMed]
  48. Pradhan, K.; Das, G.; Khan, J.; Gupta, V.; Barman, S.; Adak, A.; Ghosh, S. Neuro-Regenerative Choline-Functionalized Injectable Graphene Oxide Hydrogel Repairs Focal Brain Injury. ACS Chem. Neurosci. 2019, 10, 1535–1543. [Google Scholar] [CrossRef]
  49. Wang, Z.; Zeng, W.; Chen, Z.; Suo, W.; Quan, H.; Tan, Z.J. An intratumoral injectable nanozyme hydrogel for hypoxia-resistant thermoradiotherapy. Colloids Surf. B Biointerfaces 2021, 207, 112026. [Google Scholar] [CrossRef]
  50. Xiao, Y.; Gu, Y.; Qin, L.; Chen, L.; Chen, X.; Cui, W.; Li, F.; Xiang, N.; He, X. Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy. Colloids Surf. B Biointerfaces 2021, 200, 111581. [Google Scholar] [CrossRef]
  51. Khan, Z.M.; Wilts, E.; Vlaisavljevich, E.; Long, T.E.; Verbridge, S.S. Characterization and structure-property relationships of an injectable thiol-Michael addition hydrogel toward compatibility with glioblastoma therapy. Acta Biomater. 2022, 144, 266–278. [Google Scholar] [CrossRef]
  52. Bruns, J.; Egan, T.; Mercier, P.; Zustiak, S.P. Glioblastoma spheroid growth and chemotherapeutic responses in single and dual-stiffness hydrogels. Acta Biomater. 2023, 163, 400–414. [Google Scholar] [CrossRef]
  53. Liu, J.; Qi, C.; Tao, K.; Zhang, J.; Zhang, J.; Xu, L.; Jiang, X.; Zhang, Y.; Huang, L.; Li, Q.; et al. Sericin/Dextran Injectable Hydrogel as an Optically Trackable Drug Delivery System for Malignant Melanoma Treatment. ACS Appl. Mater. Interfaces 2016, 8, 6411–6422. [Google Scholar] [CrossRef] [PubMed]
  54. Zhang, J.; Chen, C.; Li, A.; Jing, W.; Sun, P.; Huang, X.; Liu, Y.; Zhang, S.; Du, W.; Zhang, R.; et al. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection. Nat. Nanotechnol. 2021, 16, 538–548. [Google Scholar] [CrossRef] [PubMed]
  55. Jiang, X.; Zeng, F.; Yang, X.; Jian, C.; Zhang, L.; Yu, A.; Lu, A. Injectable self-healing cellulose hydrogel based on host-guest interactions and acylhydrazone bonds for sustained cancer therapy. Acta Biomater. 2022, 141, 102–113. [Google Scholar] [CrossRef] [PubMed]
  56. Liao, Y.; Xie, L.; Ye, J.; Chen, T.; Huang, T.; Shi, L.; Yuan, M. Sprayable hydrogel for biomedical applications. Biomater. Sci. 2022, 10, 2759–2771. [Google Scholar] [CrossRef]
  57. Munoz Taboada, G.; Dahis, D.; Dosta, P.; Edelman, E.; Artzi, N. Sprayable Hydrogel Sealant for Gastrointestinal Wound Shielding. Adv. Mater. 2024, 3, e2311798. [Google Scholar] [CrossRef]
  58. Geng, H.; Dai, Q.; Sun, H.; Zhuang, L.; Song, A.; Caruso, F.; Hao, J.; Cui, J. Injectable and Sprayable Polyphenol-Based Hydrogels for Controlling Hemostasis. ACS Appl. Bio Mater. 2020, 3, 1258–1266. [Google Scholar] [CrossRef]
  59. Cai, C.; Wang, T.; Han, X.; Yang, S.; Lai, C.; Yuan, T.; Feng, Z.; He, N. In situ wound sprayable double-network hydrogel: Preparation and characterization. Chin. Chem. Lett. 2022, 33, 1963–1969. [Google Scholar] [CrossRef]
  60. McCrorie, P.; Mistry, J.; Taresco, V.; Lovato, T.; Fay, M.; Ward, I.; Ritchie, A.A.; Clarke, P.A.; Smith, S.J.; Marlow, M.; et al. Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours. Eur. J. Pharm. Biopharm. 2020, 157, 108–120. [Google Scholar] [CrossRef]
  61. Bozzato, E.; Tsakiris, N.; Paquot, A.; Muccioli, G.G.; Bastiancich, C.; Preat, V. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells. Int. J. Pharm. 2022, 628, 122341. [Google Scholar] [CrossRef] [PubMed]
  62. Cocarta, A.I.; Hobzova, R.; Sirc, J.; Cerna, T.; Hrabeta, J.; Svojgr, K.; Pochop, P.; Kodetova, M.; Jedelska, J.; Bakowsky, U.; et al. Hydrogel implants for transscleral drug delivery for retinoblastoma treatment. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 103, 109799. [Google Scholar] [CrossRef] [PubMed]
  63. Li, X.; Tang, X.; Chen, M.; Wang, P.; Liu, L.; Zhang, J.; Fan, Y. Implantable and in-vivo shape-recoverable nanocellulose-hyaluronic acid composite hydrogel. Carbohydr. Polym. 2023, 305, 120540. [Google Scholar] [CrossRef] [PubMed]
  64. Bakhrushina, E.O.; Mikhel, I.B.; Buraya, L.M.; Moiseev, E.D.; Zubareva, I.M.; Belyatskaya, A.V.; Evzikov, G.Y.; Bondarenko, A.P.; Krasnyuk, I.I., Jr.; Krasnyuk, I.I. Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents. Gels 2024, 10, 44. [Google Scholar] [CrossRef]
  65. Lyu, J.; Liu, H.; Chen, L.; Liu, C.; Tao, J.; Yao, Y.; Li, L.; Huang, Y.; Zhou, Z. In situ hydrogel enhances non-efferocytic phagocytosis for post-surgical tumor treatment. J. Control. Release 2023, 363, 402–414. [Google Scholar] [CrossRef] [PubMed]
  66. Wang, Z.; Liu, Z.; Wang, S.; Bing, X.; Ji, X.; He, D.; Han, M.; Wei, Y.; Wang, C.; Xia, Q.; et al. Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis. Asian J. Pharm. Sci. 2023, 18, 100800. [Google Scholar] [CrossRef]
  67. Zhou, B.; Fan, K.; Li, T.; Luan, G.; Kong, L. A biocompatible hydrogel-coated fiber-optic probe for monitoring pH dynamics in mammalian brains in vivo. Sens. Actuators B Chem. 2023, 380, 1334–1348. [Google Scholar] [CrossRef]
  68. Lavrador, P.; Esteves, M.R.; Gaspar, V.M.; Mano, J.F. Stimuli-Responsive Nanocomposite Hydrogels for Biomedical Applications. Adv. Funct. Mater. 2020, 31, 411–429. [Google Scholar] [CrossRef]
  69. Zhang, Y.; Dong, L.; Liu, L.; Wu, Z.; Pan, D.; Liu, L. Recent Advances of Stimuli-Responsive Polysaccharide Hydrogels in Delivery Systems: A Review. J. Agric. Food Chem. 2022, 70, 6300–6316. [Google Scholar] [CrossRef]
  70. Li, X.; Duan, L.; Kong, M.; Wen, X.; Guan, F.; Ma, S. Applications and Mechanisms of Stimuli-Responsive Hydrogels in Traumatic Brain Injury. Gels 2022, 8, 482. [Google Scholar] [CrossRef]
  71. Liu, H.; Deng, Z.; Li, T.; Bu, J.; Wang, D.; Wang, J.; Liu, M.; Li, J.; Yang, Y.; Zhong, S. Fabrication, GSH-responsive drug release, and anticancer properties of thioctic acid-based intelligent hydrogels. Colloids Surf. B Biointerfaces 2022, 217, 112703. [Google Scholar] [CrossRef] [PubMed]
  72. Albor-Ramirez, E.; Reyes-Alberto, M.; Vidal-Flores, L.M.; Gutierrez-Herrera, E.; Padilla-Castaneda, M.A. Agarose Gel Characterization for the Fabrication of Brain Tissue Phantoms for Infrared Multispectral Vision Systems. Gels 2023, 9, 944. [Google Scholar] [CrossRef]
  73. Fitzpatrick, D.P.; Kealey, C.; Brady, D.; Gately, N. Adapted sterilisation for the production of thermoresponsive hydrogels for downstream wound healing applications. Polym. Test. 2024, 132, 108379. [Google Scholar] [CrossRef]
  74. Yesilyurt, V.; Webber, M.J.; Appel, E.A.; Godwin, C.; Langer, R.; Anderson, D.G. Injectable Self-Healing Glucose-Responsive Hydrogels with pH-Regulated Mechanical Properties. Adv. Mater. 2016, 28, 86–91. [Google Scholar] [CrossRef] [PubMed]
  75. Nele, V.; Wojciechowski, J.P.; Armstrong, J.P.K.; Stevens, M.M. Tailoring Gelation Mechanisms for Advanced Hydrogel Applications. Adv. Funct. Mater. 2020, 30, 1102–1132. [Google Scholar] [CrossRef]
  76. Zhao, X.; Javed, B.; Tian, F.; Liu, K. Hydrogel on a Smart Nanomaterial Interface to Carry Therapeutics for Digitalized Glioma Treatment. Gels 2022, 8, 664. [Google Scholar] [CrossRef] [PubMed]
  77. Zhao, Y.; Ran, B.; Xie, X.; Gu, W.; Ye, X.; Liao, J. Developments on the Smart Hydrogel-Based Drug Delivery System for Oral Tumor Therapy. Gels 2022, 8, 741. [Google Scholar] [CrossRef] [PubMed]
  78. Morarasu, S.; Morarasu, B.C.; Ghiarasim, R.; Coroaba, A.; Tiron, C.; Iliescu, R.; Dimofte, G.M. Targeted Cancer Therapy via pH-Functionalized Nanoparticles: A Scoping Review of Methods and Outcomes. Gels 2022, 8, 232. [Google Scholar] [CrossRef] [PubMed]
  79. Xue, C.; Xu, X.; Zhang, L.; Liu, Y.; Liu, S.; Liu, Z.; Wu, M.; Shuai, Q. Self-healing/pH-responsive/inherently antibacterial polysaccharide-based hydrogel for a photothermal strengthened wound dressing. Colloids Surf. B Biointerfaces 2022, 218, 112738. [Google Scholar] [CrossRef]
  80. Fan, R.; Cheng, Y.; Wang, R.; Zhang, T.; Zhang, H.; Li, J.; Song, S.; Zheng, A. Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy. Polymers 2022, 14, 2379. [Google Scholar] [CrossRef]
  81. Shang, H.; Yang, X.; Liu, H. Temperature-responsive hydrogel prepared from carboxymethyl cellulose-stabilized N-vinylcaprolactam with potential for fertilizer delivery. Carbohydr. Polym. 2023, 313, 120875. [Google Scholar] [CrossRef]
  82. Wu, H.; Liu, S.; Xiao, L.; Dong, X.; Lu, Q.; Kaplan, D.L. Injectable and pH-Responsive Silk Nanofiber Hydrogels for Sustained Anticancer Drug Delivery. ACS Appl. Mater. Interfaces 2016, 8, 17118–17126. [Google Scholar] [CrossRef]
  83. Lavanya, K.; Chandran, S.V.; Balagangadharan, K.; Selvamurugan, N. Temperature- and pH-responsive chitosan-based injectable hydrogels for bone tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 111, 110862. [Google Scholar] [CrossRef] [PubMed]
  84. Ma, Z.; Yang, X.; Ma, J.; Lv, J.; He, J.; Jia, D.; Qu, Y.; Chen, G.; Yan, H.; Zeng, R. Development of the mussel-inspired pH-responsive hydrogel based on Bletilla striata polysaccharide with enhanced adhesiveness and antioxidant properties. Colloids Surf. B Biointerfaces 2021, 208, 112066. [Google Scholar] [CrossRef] [PubMed]
  85. Du, M.; Jin, J.; Zhou, F.; Chen, J.; Jiang, W. Dual drug-loaded hydrogels with pH-responsive and antibacterial activity for skin wound dressing. Colloids Surf. B Biointerfaces 2023, 222, 113063. [Google Scholar] [CrossRef] [PubMed]
  86. Xue, X.; Feng, M.; Liang, K.; Wu, Z.; Zhao, C.; Chen, Y.; Pu, H. Mesh-size adjustable hydrogel via light and pH induction. Mater. Lett. 2024, 361, 136163. [Google Scholar] [CrossRef]
  87. Kang, J.H.; Turabee, M.H.; Lee, D.S.; Kwon, Y.J.; Ko, Y.T. Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor. Biomed. Pharmacother. 2021, 143, 112144. [Google Scholar] [CrossRef] [PubMed]
  88. Lee, Y.; Kang, T.; Cho, H.R.; Lee, G.J.; Park, O.K.; Kim, S.; Lee, B.; Kim, H.M.; Cha, G.D.; Shin, Y.; et al. Localized Delivery of Theranostic Nanoparticles and High-Energy Photons using Microneedles-on-Bioelectronics. Adv. Mater. 2021, 33, e2100425. [Google Scholar] [CrossRef] [PubMed]
  89. Yang, J.; Sun, Z.; Dou, Q.; Hui, S.; Zhang, P.; Liu, R.; Wang, D.; Jiang, S. NIR-light-responsive chemo-photothermal hydrogel system with controlled DOX release and photothermal effect for cancer therapy. Colloids Surf. A Physicochem. Eng. Asp. 2023, 667, 131407. [Google Scholar] [CrossRef]
  90. Li, L.; Scheiger, J.M.; Levkin, P.A. Design and Applications of Photoresponsive Hydrogels. Adv. Mater. 2019, 31, e1807333. [Google Scholar] [CrossRef]
  91. Chen, M.; Quan, G.; Wen, T.; Yang, P.; Qin, W.; Mai, H.; Sun, Y.; Lu, C.; Pan, X.; Wu, C. Cold to Hot: Binary Cooperative Microneedle Array-Amplified Photoimmunotherapy for Eliciting Antitumor Immunity and the Abscopal Effect. ACS Appl. Mater. Interfaces 2020, 12, 32259–32269. [Google Scholar] [CrossRef] [PubMed]
  92. Gan, S.; Wu, Y.; Zhang, X.; Zheng, Z.; Zhang, M.; Long, L.; Liao, J.; Chen, W. Recent Advances in Hydrogel-Based Phototherapy for Tumor Treatment. Gels 2023, 9, 286. [Google Scholar] [CrossRef] [PubMed]
  93. Hwang, J.; Jin, J.O. Attachable Hydrogel Containing Indocyanine Green for Selective Photothermal Therapy against Melanoma. Biomolecules 2020, 10, 1124. [Google Scholar] [CrossRef] [PubMed]
  94. Zhao, M.; Bozzato, E.; Joudiou, N.; Ghiassinejad, S.; Danhier, F.; Gallez, B.; Preat, V. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection. J. Control. Release 2019, 309, 72–81. [Google Scholar] [CrossRef] [PubMed]
  95. Wang, C.; Wang, X.; Dong, K.; Luo, J.; Zhang, Q.; Cheng, Y. Injectable and responsively degradable hydrogel for personalized photothermal therapy. Biomaterials 2016, 104, 129–137. [Google Scholar] [CrossRef]
  96. Dong, X.; Liang, J.; Yang, A.; Qian, Z.; Kong, D.; Lv, F. Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy. Biomaterials 2019, 209, 111–125. [Google Scholar] [CrossRef]
  97. Li, S.; Qing, Y.; Lou, Y.; Li, R.; Wang, H.; Wang, X.; Ying, B.; Tang, X.; Qin, Y. Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement. Int. J. Biol. Macromol. 2023, 239, 124209. [Google Scholar] [CrossRef]
  98. Sang, S.; Jiang, Z.; Xie, N.; Rao, H.; Liao, K.; Hu, Q.; Zhang, Z.; Guo, R.; Fan, T.; Deng, K. Black phosphorus nanosheets and paclitaxel encapsulated hydrogel for synergistic photothermal-chemotherapy. Nanophotonics 2021, 10, 2625–2637. [Google Scholar] [CrossRef]
  99. Liu, Y.; Xi, Y.; Zhao, J.; Zhao, J.; Li, J.; Huang, G.; Li, J.; Fang, F.; Gu, L.; Wang, S. Preparation of therapeutic-laden konjac hydrogel for tumor combination therapy. Chem. Eng. J. 2019, 375, 122048. [Google Scholar] [CrossRef]
  100. Pan, H.; Zhang, C.; Wang, T.; Chen, J.; Sun, S.K. In Situ Fabrication of Intelligent Photothermal Indocyanine Green-Alginate Hydrogel for Localized Tumor Ablation. ACS Appl. Mater. Interfaces 2019, 11, 2782–2789. [Google Scholar] [CrossRef]
  101. Li, L.; Wang, C.; Huang, Q.; Xiao, J.; Zhang, Q.; Cheng, Y. A degradable hydrogel formed by dendrimer-encapsulated platinum nanoparticles and oxidized dextran for repeated photothermal cancer therapy. J. Mater. Chem. B 2018, 6, 2474–2480. [Google Scholar] [CrossRef]
  102. Wang, Y.; Pan, H.; Meng, Z.; Zhang, C. In Situ Biosynthesis of Photothermal Parasite for Fluorescence Imaging-Guided Photothermal Therapy of Tumors. Gels 2022, 8, 754. [Google Scholar] [CrossRef]
  103. Zheng, D.; Huang, C.; Hu, Y.; Zheng, T.; An, J. Constructions of synergistic photothermal therapy antibacterial hydrogel based on polydopamine, tea polyphenols and polyvinyl alcohol and effects on wound healing in mouse. Colloids Surf. B Biointerfaces 2022, 219, 112831. [Google Scholar] [CrossRef] [PubMed]
  104. Chen, L.; Chen, G.; Hu, K.; Chen, L.; Zeng, Z.; Li, B.; Jiang, G.; Liu, Y. Combined photothermal and photodynamic therapy enhances ferroptosis to prevent cancer recurrence after surgery using nanoparticle-hydrogel composite. Chem. Eng. J. 2023, 468, 1130–1148. [Google Scholar] [CrossRef]
  105. Ye, J.; Jiang, J.; Zhou, Z.; Weng, Z.; Xu, Y.; Liu, L.; Zhang, W.; Yang, Y.; Luo, J.; Wang, X. Near-Infrared Light and Upconversion Nanoparticle Defined Nitric Oxide-Based Osteoporosis Targeting Therapy. ACS Nano 2021, 15, 13692–13702. [Google Scholar] [CrossRef] [PubMed]
  106. Chang, L.; Liu, X.; Zhu, J.; Rao, Y.; Chen, D.; Wang, Y.; Zhao, Y.; Qin, J. Cellulose-based thermo-responsive hydrogel with NIR photothermal enhanced DOX released property for anti-tumor chemotherapy. Colloids Surf. B Biointerfaces 2022, 218, 112747. [Google Scholar] [CrossRef] [PubMed]
  107. Jia, Y.P.; Shi, K.; Yang, F.; Liao, J.F.; Han, R.X.; Yuan, L.P.; Hao, Y.; Pan, M.; Xiao, Y.; Qian, Z.Y.; et al. Multifunctional Nanoparticle Loaded Injectable Thermoresponsive Hydrogel as NIR Controlled Release Platform for Local Photothermal Immunotherapy to Prevent Breast Cancer Postoperative Recurrence and Metastases. Adv. Funct. Mater. 2020, 30, 1115–1138. [Google Scholar] [CrossRef]
  108. Singh, B.; Kumar, A.; Rohit. Gamma radiation formation of sterculia gum-alginate-carbopol hydrogel dressing by grafting method for use in brain drug delivery. Chem. Phys. Lett. 2021, 779, 138875. [Google Scholar] [CrossRef]
  109. Rizwan, A.; Ali, I.; Jo, S.H.; Vu, T.T.; Gal, Y.S.; Kim, Y.H.; Park, S.H.; Lim, K.T. Facile Fabrication of NIR-Responsive Alginate/CMC Hydrogels Derived through IEDDA Click Chemistry for Photothermal-Photodynamic Anti-Tumor Therapy. Gels 2023, 9, 961. [Google Scholar] [CrossRef]
  110. Wang, C.; Li, J.; Sinha, S.; Peterson, A.; Grant, G.A.; Yang, F. Mimicking brain tumor-vasculature microanatomical architecture via co-culture of brain tumor and endothelial cells in 3D hydrogels. Biomaterials 2019, 202, 35–44. [Google Scholar] [CrossRef]
  111. Maleki Dana, P.; Sadoughi, F.; Mirzaei, H.; Asemi, Z.; Yousefi, B. DNA damage response and repair in the development and treatment of brain tumors. Eur. J. Pharmacol. 2022, 924, 174957. [Google Scholar] [CrossRef] [PubMed]
  112. Gawade, P.M.; Shadish, J.A.; Badeau, B.A.; DeForest, C.A. Logic-Based Delivery of Site-Specifically Modified Proteins from Environmentally Responsive Hydrogel Biomaterials. Adv. Mater. 2019, 31, e1902462. [Google Scholar] [CrossRef] [PubMed]
  113. Wei, D.; Huang, Y.; Liang, M.; Ren, P.; Tao, Y.; Xu, L.; Zhang, T.; Ji, Z.; Zhang, Q. Polypropylene composite hernia mesh with anti-adhesion layer composed of PVA hydrogel and liposomes drug delivery system. Colloids Surf. B Biointerfaces 2023, 223, 113159. [Google Scholar] [CrossRef] [PubMed]
  114. Yu, F.; Wang, Y.; Stetler, A.R.; Leak, R.K.; Hu, X.; Chen, J. Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci. Ther. 2022, 28, 1279–1293. [Google Scholar] [CrossRef] [PubMed]
  115. Gao, Y.; Peng, K.; Mitragotri, S. Covalently Crosslinked Hydrogels via Step-Growth Reactions: Crosslinking Chemistries, Polymers, and Clinical Impact. Adv. Mater. 2021, 33, e2006362. [Google Scholar] [CrossRef] [PubMed]
  116. Jang, T.S.; Jung, H.D.; Pan, H.M.; Han, W.T.; Chen, S.; Song, J. 3D printing of hydrogel composite systems: Recent advances in technology for tissue engineering. Int. J. Bioprint. 2018, 4, 126. [Google Scholar] [CrossRef]
  117. Chen, Q.; Passos, A.; Balabani, S.; Chivu, A.; Zhao, S.; Azevedo, H.S.; Butler, P.; Song, W. Semi-interpenetrating network hyaluronic acid microgel delivery systems in micro-flow. J. Colloid Interface Sci. 2018, 519, 174–185. [Google Scholar] [CrossRef] [PubMed]
  118. Estevam, B.R.; Perez, I.D.; Moraes, Â.M.; Fregolente, L.V. A review of the strategies used to produce different networks in cellulose-based hydrogels. Mater. Today Chem. 2023, 34, 101803. [Google Scholar] [CrossRef]
  119. Gao, Y.; Meng, S.; Liu, W.; Zhang, Y.; Zhang, Y.; Dong, A.; Zhang, L. Physical Contact-Triggered In Situ Reactivation of Antibacterial Hydrogels. ACS Appl. Mater. Interfaces 2023, 15, 7735–7746. [Google Scholar] [CrossRef]
  120. Graham, S.; Marina, P.F.; Blencowe, A. Thermoresponsive polysaccharides and their thermoreversible physical hydrogel networks. Carbohydr. Polym. 2019, 207, 143–159. [Google Scholar] [CrossRef]
  121. Muir, V.G.; Burdick, J.A. Chemically Modified Biopolymers for the Formation of Biomedical Hydrogels. Chem. Rev. 2021, 121, 10908–10949. [Google Scholar] [CrossRef]
  122. Fennell, E.; Huyghe, J.M. Chemically Responsive Hydrogel Deformation Mechanics: A Review. Molecules 2019, 24, 3521. [Google Scholar] [CrossRef] [PubMed]
  123. Zhu, J.; Xu, H.; Hu, Q.; Yang, Y.; Ni, S.; Peng, F.; Jin, X. High stretchable and tough xylan-g-gelatin hydrogel via the synergy of chemical cross-linking and salting out for strain sensors. Int. J. Biol. Macromol. 2024, 261, 129759. [Google Scholar] [CrossRef]
  124. Kozicki, M.; Stempień, Z.; Rokita, B.; Dudek, M. Sandwich-type channeled chemical hydrogels manufactured by 3D ink-jet printing under freezing conditions using a photochemical process for human cell cultures. Chem. Eng. J. 2024, 481, 587–601. [Google Scholar] [CrossRef]
  125. Qin, J.; Dong, B.; Wang, W.; Cao, L. Self-regulating bioinspired supramolecular photonic hydrogels based on chemical reaction networks for monitoring activities of enzymes and biofuels. J. Colloid Interface Sci. 2023, 649, 344–354. [Google Scholar] [CrossRef] [PubMed]
  126. Zeng, L.Y.; Wang, X.C.; Wen, Y.; Chen, H.M.; Ni, H.L.; Yu, W.H.; Bai, Y.F.; Zhao, K.Q.; Hu, P. Anti-freezing dual-network hydrogels with high-strength, self-adhesive and strain-sensitive for flexible sensors. Carbohydr. Polym. 2023, 300, 120229. [Google Scholar] [CrossRef]
  127. Yuan, Y.; Wu, H.; Ren, X.; Wang, J.; Liu, R.; Hu, B.; Gu, N. Dual-network hydrogel based on ionic nano-reservoir for gastric perforation sealing. Sci. China Mater. 2021, 65, 827–835. [Google Scholar] [CrossRef]
  128. Chen, S.; Wang, Y.; Zhang, X.; Ma, J.; Wang, M. Double-crosslinked bifunctional hydrogels with encapsulated anti-cancer drug for bone tumor cell ablation and bone tissue regeneration. Colloids Surf. B Biointerfaces 2022, 213, 112364. [Google Scholar] [CrossRef]
  129. Li, P.; Li, Y.; Fu, R.; Duan, Z.; Zhu, C.; Fan, D. NIR- and pH-responsive injectable nanocomposite alginate-graft-dopamine hydrogel for melanoma suppression and wound repair. Carbohydr. Polym. 2023, 314, 120899. [Google Scholar] [CrossRef]
  130. He, W.; Chen, K.; Gao, W.; Duan, R.; Li, Z.; Li, B.; Xia, J.; Zhao, Y.; Liu, W.; Zhou, H.; et al. A sequential physical and chemical dual crosslinked multifunctional hydrogel with enhanced mechanical and osteogenic effects for vascularized bone tissue regeneration. Mater. Des. 2024, 237, 112563. [Google Scholar] [CrossRef]
  131. Song, Y.; Liu, C.; Xu, X.; Ren, L.; Zhou, X.; Xu, H.; Zhao, L.; Xin, J.; Wang, S.; Wang, Z. Chitosan-based multifunctional hydrogel with bio-adhesion and antioxidant properties for efficient wound hemostasis. Colloids Surf. B Biointerfaces 2024, 234, 113697. [Google Scholar] [CrossRef]
  132. Zhao, X.; Chen, X.; Yuk, H.; Lin, S.; Liu, X.; Parada, G. Soft Materials by Design: Unconventional Polymer Networks Give Extreme Properties. Chem. Rev. 2021, 121, 4309–4372. [Google Scholar] [CrossRef] [PubMed]
  133. Muresan, P.; McCrorie, P.; Smith, F.; Vasey, C.; Taresco, V.; Scurr, D.J.; Kern, S.; Smith, S.; Gershkovich, P.; Rahman, R.; et al. Development of nanoparticle loaded microneedles for drug delivery to a brain tumour resection site. Eur. J. Pharm. Biopharm. 2023, 182, 53–61. [Google Scholar] [CrossRef]
  134. Dai, R.; Gao, Y.; Sun, Y.; Shi, K.; Gao, G.; Zhang, H. Ionic conductive amylopectin hydrogels for biocompatible and anti-freezing wearable sensors. Eur. Polym. J. 2023, 200, 112496. [Google Scholar] [CrossRef]
  135. Indrakumar, S.; Panicker, A.T.; Parasuram, S.; Joshi, A.; Kumar Dash, T.; Mishra, V.; Tandon, B.; Chatterjee, K. 3D-printed ultra-stretchable silk fibroin-based biocompatible hydrogels. Bioprinting 2023, 36, 1133–1149. [Google Scholar] [CrossRef]
  136. Moura, D.; Rohringer, S.; Ferreira, H.P.; Pereira, A.T.; Barrias, C.C.; Magalhaes, F.D.; Bergmeister, H.; Goncalves, I.C. Long-term in vivo degradation and biocompatibility of degradable pHEMA hydrogels containing graphene oxide. Acta Biomater. 2024, 173, 351–364. [Google Scholar] [CrossRef]
  137. Lessmann, T.; Jones, S.A.; Voigt, T.; Weisbrod, S.; Kracker, O.; Winter, S.; Zuniga, L.A.; Stark, S.; Bisek, N.; Sprogoe, K. Degradable Hydrogel for Sustained Localized Delivery of Anti-Tumor Drugs. J. Pharm. Sci. 2023, 112, 2843–2852. [Google Scholar] [CrossRef] [PubMed]
  138. Wang, H.; Chen, X.; Gong, C.; Bu, Y.; Wu, T.; Yan, H.; Lin, Q. Intelligent response organo-montmorillonite/Fe3+-alginate/poly (N-isopropylacrylamide) interpenetrating network composite hydrogels for controlled release of water-insoluble pesticides. Appl. Clay Sci. 2024, 251, 107302. [Google Scholar] [CrossRef]
  139. Li, Y.; Zhang, L.; Song, Z.; Li, F.; Xie, D. Intelligent temperature-pH dual responsive nanocellulose hydrogels and the application of drug release towards 5-fluorouracil. Int. J. Biol. Macromol. 2022, 223, 11–16. [Google Scholar] [CrossRef]
  140. Cai, Y.; Xin, L.; Sun, P.; Li, H.; Liu, C.; Fang, L. Temperature-sensitive multifunctional intelligent responsive hydrogel based on carboxymethyl agarose and N-isopropylacrylamide: Controlled drug release and accelerated wound healing. Carbohydr. Polym. 2023, 322, 121327. [Google Scholar] [CrossRef]
  141. Liu, J.; Yu, J.; Xu, C.; Li, B.; Liu, L.; Lu, C.; Fan, Y. One-pot and one-step preparation of “living” cellulose nanofiber hydrogel with active double-bond via chemical vapor deposition. Int. J. Biol. Macromol. 2023, 245, 125415. [Google Scholar] [CrossRef] [PubMed]
  142. Yang, Z.; Yu, S.; Chen, H.; Guo, X.; Cai, P.; Meng, H. One-step electrogelation of pectin hydrogels as a simpler alternative for antibacterial 3D printing. Colloids Surf. A Physicochem. Eng. Asp. 2022, 654, 1229964. [Google Scholar] [CrossRef]
  143. Liu, Y.; Zhu, Y.; Mu, B.; Zong, L.; Wang, X.; Wang, A. One-step green construction of granular composite hydrogels for ammonia nitrogen recovery from wastewater for crop growth promotion. Environ. Technol. Innov. 2024, 33, 103465. [Google Scholar] [CrossRef]
  144. Li, X.; Gong, N.; Tian, F.; Zhang, S.; Zhang, Y.; Wang, Y.; Qing, G.; Wang, Y.; Li, F.; Xu, Y.; et al. Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel. Nat. Biomed. Eng. 2023, 7, 1129–1141. [Google Scholar] [CrossRef] [PubMed]
  145. Zhang, J.; Wei, X.; Liu, W.; Wang, Y.; Kahkoska, A.R.; Zhou, X.; Zheng, H.; Zhang, W.; Sheng, T.; Zhang, Y.; et al. Week-long norm glycaemia in diabetic mice and minipigs via a subcutaneous dose of a glucose-responsive insulin complex. Nat. Biomed. Eng. 2023, 1557–1584. [Google Scholar] [CrossRef]
  146. Tondera, C.; Wieduwild, R.; Röder, E.; Werner, C.; Zhang, Y.; Pietzsch, J. In Vivo Examination of an Injectable Hydrogel System Crosslinked by Peptide-Oligosaccharide Interaction in Immunocompetent Nude Mice. Adv. Funct. Mater. 2017, 27, 113–127. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yang, J.; Wang, Z.; Ma, C.; Tang, H.; Hao, H.; Li, M.; Luo, X.; Yang, M.; Gao, L.; Li, J. Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors. Gels 2024, 10, 404. https://doi.org/10.3390/gels10060404

AMA Style

Yang J, Wang Z, Ma C, Tang H, Hao H, Li M, Luo X, Yang M, Gao L, Li J. Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors. Gels. 2024; 10(6):404. https://doi.org/10.3390/gels10060404

Chicago/Turabian Style

Yang, Jingru, Zhijie Wang, Chenyan Ma, Hongyu Tang, Haoyang Hao, Mengyao Li, Xianwei Luo, Mingxin Yang, Liang Gao, and Juan Li. 2024. "Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors" Gels 10, no. 6: 404. https://doi.org/10.3390/gels10060404

APA Style

Yang, J., Wang, Z., Ma, C., Tang, H., Hao, H., Li, M., Luo, X., Yang, M., Gao, L., & Li, J. (2024). Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors. Gels, 10(6), 404. https://doi.org/10.3390/gels10060404

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop